Hong Kong MDACS vs India CDSCO: A Complete Guide to Medical Device Registration
Introduction
Medical device manufacturers planning to enter Asian markets must understand the regulatory requirements of each destination before importing or commercializing their products. Hong Kong and India are both important healthcare markets, but their medical device regulatory frameworks differ in structure, regulatory procedures, and market-entry requirements.
Hong Kong’s Medical Device Administrative Control System (MDACS) is administered by the Medical Device Division of the Department of Health. India’s medical device regulatory framework is governed by the Central Drugs Standard Control Organization (CDSCO), under the Ministry of Health and Family Welfare, with requirements established under India’s Medical Devices Rules, 2017.
The key difference is that Hong Kong’s MDACS operates as an administrative listing system, whereas India’s framework provides for regulated licensing and registration requirements according to the applicable medical device category and activity.
This guide compares MDACS and CDSCO, explains the principal registration considerations, and helps manufacturers, importers, and regulatory professionals plan their market-entry strategy.
Explore more global medical device registration.
Quick answer: What is the difference between MDACS and CDSCO?
Comparison factor | Hong Kong MDACS | India CDSCO |
Regulatory authority | Department of Health, Medical Device Division | CDSCO, under the Ministry of Health and Family Welfare, with state licensing authorities also involved |
Regulatory framework | Medical Device Administrative Control System | Medical Devices Rules, 2017, as amended |
General regulatory approach | Administrative listing framework | Statutory licensing and regulatory framework |
Device classification | Class I, II, III, IV under MDACS | Class A, B, C, D |
Market-entry route | Applicable MDACS listing and related requirements, depending on the device and activity | Applicable import, manufacturing, and other permissions based on device class and activity |
Local involvement | Local Responsible Person (LRP) requirements may apply | Indian authorized agent, importer, or licensed manufacturer requirements may apply, depending on the route |
Documentation | Device information, conformity and safety evidence, and other documents applicable to the listing | Device-specific technical, quality, safety, performance, and licensing documentation |
Regulatory planning | Confirm the relevant MDACS listing route and current requirements | Confirm the applicable CDSCO or state licensing route and current requirements |
Important: The two classification systems are not interchangeable. A device’s class in Hong Kong does not automatically establish its class in India.
Understanding Hong Kong's MDACS framework
The Medical Device Administrative Control System (MDACS) is administered by the Medical Device Division of Hong Kong’s Department of Health. It is a voluntary listing system for specified categories of medical devices and in vitro diagnostic medical devices, alongside a post-market monitoring system.
Medical Device Administrative Control System
Under the current framework:
- General medical devices are classified into Classes I, II, III, and IV.
- In vitro diagnostic medical devices (IVDMDs) are classified into Classes A, B, C, and D.
- The MDACS device-listing system covers general medical devices in Classes II, III, and IV and IVDMDs in Classes B, C, and D.
- Class I general medical devices and Class A IVDMDs are outside the current device-listing scope, although other applicable requirements must still be checked.
The MDACS framework is designed to support the safety, quality, and performance of medical devices supplied in Hong Kong. Healthcare institutions and the public are advised to choose MDACS-listed devices wherever possible.
How does medical device listing work in Hong Kong?
The general process involves the following steps:
Step 1: Determine device classification
Identify the device type, intended purpose, and applicable MDACS classification.
Step 2: Identify the appropriate applicant
Confirm whether a Local Responsible Person (LRP) and any applicable trader listing are required for the proposed activity.
Step 3: Prepare the application documents
Compile the applicable conformity evidence, product information, safety and performance documentation, labeling, and supporting certificates.
Step 4: Submit through the applicable system
Follow the current Medical Device Information System (MDIS) procedures and the relevant guidance for the device and applicant.
Step 5: Maintain compliance
Keep listing information current and meet applicable post-market monitoring, reporting, and change-control obligations.
The exact documentation and eligibility requirements depend on the device category, conformity assessment route, and applicable guidance. Manufacturers should consult the official MDACS listing application information pack.
Manufacturers planning to enter Hong Kong should understand the applicable device classification, listing criteria, and documentation requirements before submitting an application. For a more detailed overview, see ElendiLabs‘ guide to Hong Kong Medical Device Registration: MDACS Listing.
Understanding India's CDSCO regulatory framework
India regulates medical devices under the Medical Devices Rules, 2017, as amended, with CDSCO serving as the central regulatory authority and state licensing authorities handling certain responsibilities.
The framework establishes risk-based classification and requirements for manufacturing, importing, and other regulated activities.
Medical device classification in India
India classifies medical devices into four risk categories:
Device class | Risk category |
Class A | Low risk |
Class B | Low-moderate risk |
Class C | Moderate-high risk |
Class D | High risk |
Classification depends on factors such as intended use, duration of contact, invasiveness, and the potential risk to patients or users. The applicable classification rules must be evaluated for the individual device.
Accelerate Market Access with End-to-End Regulatory Guidance
What is the CDSCO registration or licensing process?
The correct route depends on whether the applicant intends to import a device, manufacture it in India, or conduct another regulated activity.
For an overseas manufacturer seeking to import medical devices into India, the typical process includes:
- Confirm the device’s regulatory status. Determine its intended use, classification, and applicable regulatory requirements.
- Appoint an authorized Indian agent. The overseas manufacturer generally appoints an authorized agent to handle the import application and associated regulatory responsibilities.
- Prepare the technical dossier. Compile the applicable device information, manufacturing-site information, quality documents, labeling, safety and performance evidence, and other supporting records.
- Submit the import application. For the standard import-licence route, the application is made in Form MD-14, with the import licence issued in Form MD-15 when granted.
- Address regulatory queries. Respond to requests for clarification or additional evidence from the relevant licensing authority.
- Maintain compliance after authorization. Keep licenses and supporting documentation current and meet applicable post-market and change-notification requirements.
CDSCO’s official guidance identifies MD-14 as the application form and MD-15 as the import licence for medical devices.
Important: Not every device follows an identical licensing route. Applicable exemptions, class-specific provisions, transitional requirements, and amendments must be checked against the current rules before filing.
For further information, visit the official CDSCO Medical Devices Rules page.
MDACS vs CDSCO: Key regulatory differences
Although both frameworks consider medical device safety and risk, their regulatory mechanisms differ significantly.
Area | Hong Kong MDACS | India CDSCO |
Regulatory model | Administrative listing system | Statutory regulatory and licensing system |
Risk classes | I–IV for general medical devices; A–D for IVDMDs | A–D |
Product authorization | Listing under MDACS where applicable | Applicable import or manufacturing licence or other authorization |
Applicant arrangements | LRP and relevant trader-listing requirements, where applicable | Authorized Indian agent, importer, manufacturer, or other applicable regulated entity |
Technical documentation | Documentation prescribed for the applicable MDACS route | Documentation prescribed under the applicable provisions of the Medical Devices Rules |
Manufacturing oversight | Requirements depend on the applicable listing and conformity assessment framework | Licensing, quality-system, and inspection requirements depend on the applicable manufacturing route |
Post-market compliance | Applicable vigilance, reporting, and listing-maintenance obligations | Applicable vigilance, reporting, quality, and licence-maintenance obligations |
A critical distinction is that MDACS listing should not be treated as equivalent to an Indian import licence, and an Indian CDSCO licence does not automatically establish eligibility for MDACS listing.
Each market has its own rules, application requirements, and regulatory decisions.
Documentation required for medical device registration
Documentation is one of the most important parts of regulatory planning. A complete dossier helps demonstrate that a device meets the applicable safety, quality, and performance requirements.
The exact document checklist depends on the product and regulatory pathway.
Common documentation areas
Document category | Purpose |
Device description and intended use | Defines the product, its purpose, and how it will be used |
Classification rationale | Explains the proposed risk classification |
Technical documentation | Describes design, specifications, components, and manufacturing information |
Safety and performance evidence | Supports conformity with applicable regulatory requirements |
Risk management documentation | Identifies and evaluates product risks and their controls |
Quality management system evidence | Demonstrates relevant quality-system compliance |
Labeling and instructions for use | Provides product identification, warnings, directions, and other required information |
Clinical or performance evidence | Supports safety and performance claims where required |
Manufacturing and authorization documents | Establishes the identity and regulatory standing of relevant manufacturers and applicants |
Free Sale Certificate or other regulatory certificates | Provides supporting evidence where required by the relevant pathway |
India’s CDSCO import-licence documentation checklist, for example, identifies supporting materials such as a power of attorney, regulatory certificates where applicable, quality-system evidence, manufacturer declarations, and device master-file information.
For Hong Kong, applicants should use the relevant current MDACS guidance rather than assume that an Indian submission dossier can be reused without modification.
Can a CDSCO-approved medical device be listed in Hong Kong under MDACS?
Not automatically. An existing CDSCO authorization may form part of a manufacturer’s regulatory history or supporting evidence, but it does not by itself establish that the device qualifies for MDACS listing.
The manufacturer or applicant should:
- Confirm that the product falls within the relevant MDACS scope.
- Determine the applicable device class and conformity assessment requirements.
- Identify the appropriate LRP and applicant arrangements.
- Check which prior market approvals and supporting documents are acceptable under the current MDACS guidance.
- Submit the required application and evidence through the applicable process.
Likewise, an MDACS listing should not be assumed to satisfy India’s CDSCO licensing requirements.
The regulatory route should be assessed independently for each market, based on the device’s intended use, risk classification, manufacturing arrangements, and planned commercial activity.
Common challenges when entering both markets
Manufacturers pursuing Hong Kong and India may encounter several practical challenges.
Different classification systems
Hong Kong’s general medical device classes I–IV do not map directly to India’s Classes A–D. Manufacturers should document a separate classification rationale for each market.
Incomplete or inconsistent technical files
Differences in product names, intended use, specifications, manufacturing-site details, and labeling across documents can trigger questions during regulatory review.
Local representation and importer responsibilities
Applicant eligibility and local responsibilities differ between markets. Manufacturers should identify the correct local entities and clarify their responsibilities before submitting applications.
Evidence and certificate requirements
A certificate accepted in one jurisdiction may not satisfy the requirements of another. Applicants should verify the current list of accepted evidence and any authentication requirements.
Regulatory changes
Regulatory guidance can change. For example, Hong Kong’s Medical Device Division announced updates to several MDACS guidance notes effective September 1, 2026. Applicants should verify the current guidance before filing.
How manufacturers can plan a regulatory strategy for Hong Kong and India
A coordinated regulatory plan can reduce duplication and make market entry more predictable.
- Create a product regulatory profile. Document intended use, device type, classification rationale, manufacturing location, and existing approvals.
- Map each market’s requirements. Review current MDACS guidance for Hong Kong and the Medical Devices Rules, 2017, as amended, for India.
- Identify local applicant requirements. Confirm the LRP and trader requirements in Hong Kong and the appropriate authorized agent or licensee arrangements in India.
- Build a core technical dossier. Maintain a controlled set of accurate product and manufacturing records, then adapt it to each jurisdiction’s requirements.
- Plan submissions independently. Do not assume that approval or listing in one market replaces the requirements of the other.
- Maintain post-market compliance. Establish procedures for complaints, vigilance, field safety actions, changes, and regulatory updates as applicable.
For manufacturers seeking assistance with the Indian regulatory pathway, Operon Strategist’s CDSCO medical device registration guide provides a relevant starting point.
Conclusion
Hong Kong MDACS and India’s CDSCO framework serve different regulatory environments, and medical device manufacturers should not assume that compliance in one market automatically establishes compliance in the other.
MDACS uses a voluntary listing framework for specified device categories, while India’s Medical Devices Rules, 2017, establish the applicable licensing and regulatory requirements for medical device activities. Classification, documentation, local representation, and post-market responsibilities must be assessed for each jurisdiction.
A well-planned regulatory strategy starts with understanding the product, identifying the correct pathway in each market, and preparing consistent technical documentation that meets the relevant requirements.
For companies planning to enter India, Operon Strategist’s medical device regulatory consulting and CDSCO registration resources can help them understand the applicable regulatory pathway and plan their submissions.
Source links for regulatory verification
The following sources should be used to verify the article before publication. Official regulatory sources should take priority over secondary sources.
- Hong Kong Department of Health — MDACS
Official overview of the system, scope, and listed-device framework.
Read the official MDACS guidance
- MDACS listing application information pack
Application resources and documentation guidance for device listing.
Review listing application resources
- MDACS guidance updates — September 2026
Recent changes to guidance for the MDACS framework and trader listings.
Review the September 2026 update
- CDSCO — Medical Devices Rules, 2017
India’s official rules and amendment repository.
Access the Medical Devices Rules
- CDSCO — Medical Device and Diagnostics
Regulatory classification and information about import and manufacturing licences.
- ElendiLabs — Hong Kong Medical Device Registration: MDACS Listing
Suggested external reference for the Hong Kong regulatory section and your reciprocal backlink.
Get Your Medical Device Market-Ready with Expert Regulatory Support
FAQ's
What is the difference between MDACS and CDSCO?
MDACS is Hong Kong’s Medical Device Administrative Control System, a voluntary listing system for specified medical devices and IVDs. CDSCO is India’s central regulatory authority responsible for medical device regulation under the Medical Devices Rules, 2017, as amended. India’s framework includes applicable import and manufacturing licensing requirements.
Is MDACS registration mandatory in Hong Kong?
MDACS is a voluntary listing system for the device categories within its scope. However, manufacturers and importers must assess all other applicable legal and regulatory obligations. Voluntary listing does not mean that every medical device activity is exempt from regulation.
What are the medical device classes in Hong Kong and India?
Hong Kong uses Classes I, II, III, and IV for general medical devices, and Classes A, B, C, and D for IVD medical devices. India uses Classes A, B, C, and D for medical devices based on risk. The classifications should be assessed independently.
What is Form MD-15 in India?
Form MD-15 is the import licence issued under the Medical Devices Rules, 2017, following the applicable application process. The standard application for an import licence is made in Form MD-14. Requirements depend on the product and applicable regulatory provisions.
Can an overseas medical device manufacturer apply directly to CDSCO?
An overseas manufacturer generally appoints an authorized Indian agent to handle the applicable import-licence application and related regulatory responsibilities. The applicant must meet the relevant eligibility and documentation requirements.
Does a CE certificate guarantee medical device registration in Hong Kong or India?
No. A CE certificate does not automatically guarantee MDACS listing or an Indian CDSCO licence. Its acceptability and relevance depend on the applicable regulatory pathway and supporting evidence requirements.
What documents are required for medical device registration?
Common documentation areas include device descriptions, intended use, classification rationale, technical files, risk management, safety and performance evidence, labeling, and relevant quality-system and regulatory certificates. The precise requirements depend on the jurisdiction, device type, and application route.
Where can manufacturers find official regulatory guidance?
For Hong Kong, consult the Medical Device Division’s MDACS website. For India, consult the CDSCO Medical Devices Rules page.